Martin Ingvar Selected Research

Martin Ingvar Research Topics

Disease

17	Pain (Aches) 01/2019 - 03/2002
4	Chronic Pain 01/2017 - 07/2009
4	Fibromyalgia (Fibrositis) 01/2017 - 01/2014
3	Bipolar Disorder (Manic Depressive Psychosis) 01/2022 - 12/2019
3	Mental Disorders (Mental Disorder) 11/2020 - 12/2017
3	Alzheimer Disease (Alzheimer's Disease) 11/2006 - 03/2006
2	Amphetamine-Related Disorders (Addiction, Amphetamine) 01/2022 - 10/2018
2	Psychotic Disorders (Schizoaffective Disorder) 01/2021 - 01/2017
2	Inflammation (Inflammations) 01/2019 - 01/2018
2	Fatigue 01/2019 - 01/2018
2	Hyperalgesia 06/2015 - 06/2009
1	Substance-Related Disorders (Drug Abuse) 01/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2020
1	Mania (Manias) 01/2020
1	Necrosis 01/2019
1	Schizophrenia (Dementia Praecox) 01/2018
1	Hypersensitivity (Allergy) 01/2018
1	Cerebral Cortical Thinning 01/2018
1	Sleepiness 01/2018
1	Autistic Disorder (Autism) 01/2017
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2017
1	Hot Flashes 05/2014
1	Breast Neoplasms (Breast Cancer) 05/2014
1	Prostatic Neoplasms (Prostate Cancer) 05/2014
1	Major Depressive Disorder (Major Depressive Disorders) 02/2012
1	Illusions (Auditory Illusions) 01/2012
1	Nausea 03/2011
1	Neoplasms (Cancer) 03/2011
1	Vomiting 03/2011
1	Acute Pain 07/2009
1	Mood Disorders (Mood Disorder) 04/2008
1	Occupational Stress 10/2006
1	Depressive Disorder (Melancholia) 10/2006
1	Alcoholism (Alcohol Abuse) 01/2006
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 08/2002

Drug/Important Bio-Agent (IBA)

7	Opioid Analgesics (Opioids)IBA 10/2018 - 03/2002
5	Pharmaceutical PreparationsIBA 01/2022 - 01/2006
3	Interleukin-6 (Interleukin 6)IBA 01/2019 - 02/2012
3	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 11/2016 - 03/2011
3	Analgesics (Analgesic Drugs)IBA 06/2015 - 06/2005
3	Serotonin (5 Hydroxytryptamine)IBA 12/2014 - 07/2009
3	ApolipoproteinsIBA 11/2006 - 03/2006
2	LithiumIBA 01/2022 - 01/2020
2	Interleukin-8 (Interleukin 8)IBA 01/2019 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 11/2016
2	Apolipoproteins E (ApoE)IBA 05/2006 - 03/2006
1	Hallucinogens (Psychedelics)IBA 01/2021
1	Calcium Channels (Calcium Channel)IBA 12/2019
1	LipopolysaccharidesIBA 01/2019
1	Naltrexone (ReVia)FDA LinkGeneric 10/2018
1	Narcotic Antagonists (Opioid Antagonists)IBA 10/2018
1	Complement System Proteins (Complement)IBA 01/2018
1	Interleukin-5 (Interleukin 5)IBA 01/2018
1	Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA 01/2018
1	Oxazepam (Serax)FDA LinkGeneric 03/2017
1	A-factor (Streptomyces)IBA 01/2017
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 12/2014
1	Milnacipran (Ixel)FDA Link 12/2014
1	Antidepressive Agents (Antidepressants)IBA 12/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2012
1	5-HT1A Serotonin ReceptorIBA 01/2012
1	salicylhydroxamic acid (SHAM)IBA 03/2011
1	AntiemeticsIBA 03/2011
1	PC6 extract (PC6)IBA 03/2011
1	5-HT1 Serotonin ReceptorsIBA 07/2009
1	Remifentanil (Ultiva)FDA Link 07/2009
1	Pain-FreeIBA 07/2009
1	valylvaline (Val-Val)IBA 06/2009
1	Opiate AlkaloidsIBA 06/2009
1	methionylmethionine (Met-Met)IBA 06/2009
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2006
1	Corticotropin-Releasing HormoneIBA 10/2006
1	C-PeptideIBA 08/2002
1	Insulin (Novolin)FDA Link 08/2002

Therapy/Procedure

7	Analgesia 01/2017 - 03/2002
5	Therapeutics 11/2020 - 06/2005
2	Aftercare (After-Treatment) 12/2014 - 07/2012
2	Intravenous Injections 07/2009 - 06/2009
1	Continuity of Patient Care 01/2020
1	Acupuncture Therapy 05/2014
1	Tourniquets 03/2011
1	Radiotherapy 03/2011
1	Acupuncture Points (Acupuncture Point) 03/2011
1	Patient-Controlled Analgesia (Analgesia, Patient Controlled) 06/2005